# Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study

Study · id `cardio:ct-nct02343393` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02343393](<https://clinicaltrials.gov/study/NCT02343393>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02343393

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT02343393. Randomized; single masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT02343393, source copy `cardio:ctgov-nct02343393-2015-01-22`, retrieved 2026-10-26)
- Start date: 2015-01 (registry gives no type) (ClinicalTrials.gov record NCT02343393, source copy `cardio:ctgov-nct02343393-2015-01-22`, retrieved 2026-10-26)
- Primary completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT02343393, source copy `cardio:ctgov-nct02343393-2015-01-22`, retrieved 2026-10-26)
- Completion: 2016-06 (anticipated) (ClinicalTrials.gov record NCT02343393, source copy `cardio:ctgov-nct02343393-2015-01-22`, retrieved 2026-10-26)
- Countries: Singapore (ClinicalTrials.gov record NCT02343393, source copy `cardio:ctgov-nct02343393-2015-01-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02343393-2015-01-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study
- Acronym: NICHE
- Condition: Cardio-Renal Syndrome
- Intervention (Drug): Hydralazine
- Intervention (Drug): Isosorbide Dinitrate
- Lead sponsor: National University Hospital, Singapore
- Lead sponsor class: OTHER
- Collaborator: Singapore Clinical Research Institute
- Collaborator class: OTHER
- Collaborator: Changi General Hospital
- Collaborator class: OTHER
- Collaborator: National Heart Centre Singapore
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: National University Hospital, Singapore (`cardio:org-national-university-hospital-singapore`)
- Registry lists this organization as a collaborator: Singapore Clinical Research Institute (`cardio:org-singapore-clinical-research-institute`)
- Registry lists this organization as a collaborator: Changi General Hospital (`cardio:org-changi-general-hospital`)
- Registry lists this organization as a collaborator: National Heart Centre Singapore (`cardio:org-national-heart-centre-singapore`)

## Provenance

Content hash: 3ced53758e14fc3c6666ff453c024f032d0f46d249886581513d673ccfa77630
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
